CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
about
Bone marrow-derived dendritic cells pulsed with tumor lysates induce anti-tumor immunity against gastric cancer ex vivoEffects of 7,8-dihydro-8-oxo-deoxyguanosine on antigen challenge in ovalbumin-sensitized mice may be mediated by suppression of Rac.CTLA4 is expressed on mature dendritic cells derived from human monocytes and influences their maturation and antigen presentation.Trends in cancer immunotherapyGene carriers and transfection systems used in the recombination of dendritic cells for effective cancer immunotherapy.Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.Harnessing dendritic cells for tumor antigen presentationThe Importance of Lamivudine Therapy in Liver Cirrhosis Patients Related HBV with Advanced Hepatocellular Carcinoma Receiving Hepatic Arterial Infusion ChemotherapyThe evolving role of dendritic cells in cancer therapy.Immunotherapeutic modulation of the suppressive liver and tumor microenvironments.Spontaneous and therapeutic immune responses in hepatocellular carcinoma: implications for current and future immunotherapies.Current concepts of immune based treatments for patients with HCC: from basic science to novel treatment approaches.Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy.CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging.Improving immunotherapy of hepatocellular carcinoma (HCC) using dendritic cells (DC) engineered to express IL-12 in vivo.Kinase inhibitor Sorafenib modulates immunosuppressive cell populations in a murine liver cancer model.CD40 ligand induced cytotoxicity in carcinoma cells is enhanced by inhibition of metalloproteinase cleavage and delivery via a conditionally-replicating adenovirus.A phase II study of adoptive immunotherapy using dendritic cells pulsed with tumor lysate in patients with hepatocellular carcinoma.Adenovirus co-expressing CD40 ligand and interleukin (IL)-2 contributes to maturation of dendritic cells and production of IL-12.Therapeutic vaccine to cure large mouse hepatocellular carcinomas.Role of relevant immune-modulators and cytokines in hepatocellular carcinoma and premalignant hepatic lesions.Immunotherapy of hepatocellular carcinomaImmunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progressionCombinational immune-cell therapy of natural killer cells and sorafenib for advanced hepatocellular carcinoma: a review
P2860
Q33393205-60441032-7F90-4386-AF62-06EEED103E43Q33569531-00335375-63A7-42C1-A32E-F3ABAF3EAF88Q33849506-D44DD014-C62A-43C1-AEE3-A788A7BA10A7Q34052702-2976230C-5880-4CD0-888F-8980C7EC1ABCQ34443707-025666B3-20F7-48E8-9D62-1B7FA0A884F9Q35077803-8034FF4D-8B49-40DA-84E7-356672C58EC0Q37132747-7511E5A1-AEE4-4156-BC11-562EB7F34296Q37204018-D078636D-512C-4BBA-9592-0D90B81E8FD2Q37687418-D7623731-A124-477D-9395-9D2B85F3AF8DQ37829504-B2BC6792-B032-4191-B5B2-FBF4215FA6BBQ38177324-321EBDDF-1DBD-4E7B-98AD-B669F4830B5AQ38349665-0B6F46D6-8E19-4672-BB6E-E61AC56DC729Q38527482-E2D25CD2-0BC4-4719-A516-35E561183443Q39048893-84DAE0CE-5090-4407-9E65-9E968ABF5FF3Q39101230-E18F65C4-58F0-4F8B-9C79-6B457B4B86AAQ39592084-D72FB1FB-90BC-4A16-ACAD-40C8E62C66DCQ39731032-22B6266C-35AE-4DD7-B6BD-F61AF5318DA0Q39922106-7D55D394-12D2-4134-BFC6-052826AB223AQ40437659-B62E1397-7CD2-41B1-B4A0-018914C5A7B0Q41592594-2A537C95-0915-4408-81CD-F44D88BC579DQ53699261-E85814AD-58BF-4FB9-A364-9402F2D54C3BQ56896669-3352E9EC-AA79-4E15-A893-A9438ED8AFB5Q58731797-C9175B34-45B7-4EFC-BD9C-D6767ADD5AD9Q58755253-E8BAAE20-5CF0-4C5D-BF2C-AFFEBB1CF3DA
P2860
CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
CD40ligand-expressing dendriti ...... and acquired immunity in vivo.
@en
CD40ligand-expressing dendriti ...... and acquired immunity in vivo.
@nl
type
label
CD40ligand-expressing dendriti ...... and acquired immunity in vivo.
@en
CD40ligand-expressing dendriti ...... and acquired immunity in vivo.
@nl
prefLabel
CD40ligand-expressing dendriti ...... and acquired immunity in vivo.
@en
CD40ligand-expressing dendriti ...... and acquired immunity in vivo.
@nl
P2093
P356
P1433
P1476
CD40ligand-expressing dendriti ...... and acquired immunity in vivo.
@en
P2093
Annabelle Vogt
Anne Timmerman
Elisabeth Sievers
Ingo G H Schmidt-Wolf
Maria A Gonzalez-Carmona
Sara Shabani
Tilman Sauerbruch
Veronika Lukacs-Kornek
Volker Schmitz
Wolfgang H Caselmann
P2860
P304
P356
10.1002/HEP.22296
P407
P577
2008-07-01T00:00:00Z